Biora Therapeutics Inc.

NASDAQ: PROG · Real-Time Price · USD
0.88
-0.04 (-3.96%)
At close: May 09, 2022, 6:00 AM

Biora Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
107K 602K 182K 463K 24.53M
Cost of Revenue
n/a n/a n/a n/a 22.23M
Gross Profit
107K 602K 182K 463K 2.29M
Operating Income
-16.57M -90.84M -30.56M -35.65M -46.25M
Interest Income
n/a n/a 467K 2.9M 14.85M
Pretax Income
-14.49M -68.1M -36.87M -41.4M -32.26M
Net Income
-11.73M -67.98M -43.74M -78.53M -32.26M
Selling & General & Admin
13.46M -4.8M 18.52M 22.71M 36.87M
Research & Development
6.56M 8.48M 12.23M 13.4M 11.67M
Other Expenses
n/a n/a n/a n/a n/a
Operating Expenses
20.02M 3.69M 30.74M 36.12M 48.54M
Interest Expense
-2.76M 2.16M 3.46M 3.5M 3.52M
Selling & Marketing Expenses
n/a -12.47M 573K 2.01M 14.65M
Cost & Expenses
20.02M 3.69M 30.74M 36.12M 70.77M
Income Tax Expense
-2.76M -119K -2.85M -2.25M n/a
Shares Outstanding (Basic)
183.2M 166.07M 95.85M 63.94M 57.49M
Shares Outstanding (Diluted)
183.2M 166.07M 95.85M 63.94M 57.49M
EPS (Basic)
-0.06 -0.41 -0.46 -1.23 -0.56
EPS (Diluted)
-0.06 -0.41 -0.46 -1.23 -0.56
EBITDA
-16.25M -90.46M -40.19M -75.31M -27.5M
EBIT
-17.25M -65.95M -33.42M -37.9M -28.74M
Depreciation & Amortization
322K 373K 99K -284K 1.25M